Literature DB >> 16040883

How has research in the last five years changed my clinical practice?

A Bush1.   

Abstract

UNLABELLED: The first instruction to examination candidates is to read and answer the question actually set. Doing so in this case leads to the following
CONCLUSIONS: how research has changed my clinical practice includes the act of doing research, as well as reading about the work of others. Thus, this article refers to my own clinical practice (tertiary referral paediatric respiratory medicine in a setting where we do not service an accident and emergency department), rather than that of others. This means excluding important conditions such as acute croup and uncomplicated community acquired pneumonia. I should write about what has changed my practice, not what other people think I ought to have changed. So this will be a personal view, limited to research published in a peer review format at the time of writing. I shall also assume that change is an ongoing process, so I shall include change in progress, provided it is supported by published literature.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040883      PMCID: PMC1720534          DOI: 10.1136/adc.2004.066241

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  43 in total

1.  Clinical improvement in cystic fibrosis with early insulin treatment.

Authors:  L Dobson; A T Hattersley; S Tiley; S Elworthy; P J Oades; C D Sheldon
Journal:  Arch Dis Child       Date:  2002-11       Impact factor: 3.791

2.  Primary ciliary dyskinesia.

Authors:  A Bush; C O'Callaghan
Journal:  Arch Dis Child       Date:  2002-11       Impact factor: 3.791

3.  BTS guidelines for the management of pleural infection in children.

Authors:  I M Balfour-Lynn; E Abrahamson; G Cohen; J Hartley; S King; D Parikh; D Spencer; A H Thomson; D Urquhart
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

4.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

Authors:  Ruth H Green; Christopher E Brightling; Susan McKenna; Beverley Hargadon; Debbie Parker; Peter Bradding; Andrew J Wardlaw; Ian D Pavord
Journal:  Lancet       Date:  2002-11-30       Impact factor: 79.321

5.  Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis.

Authors:  Sarah L Elkin; Shobna Vedi; Sharyn Bord; Nigel J Garrahan; Margaret E Hodson; Juliet E Compston
Journal:  Am J Respir Crit Care Med       Date:  2002-09-11       Impact factor: 21.405

6.  Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia.

Authors:  B Karadag; A J James; E Gültekin; N M Wilson; A Bush
Journal:  Eur Respir J       Date:  1999-06       Impact factor: 16.671

7.  Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial.

Authors:  A Equi; I M Balfour-Lynn; A Bush; M Rosenthal
Journal:  Lancet       Date:  2002-09-28       Impact factor: 79.321

8.  Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom.

Authors:  G R G Todd; C L Acerini; R Ross-Russell; S Zahra; J T Warner; D McCance
Journal:  Arch Dis Child       Date:  2002-12       Impact factor: 3.791

9.  Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial.

Authors:  Alan Smyth; Kelvin H-V Tan; Pauline Hyman-Taylor; Michael Mulheran; Sarah Lewis; David Stableforth; Alan Prof Knox
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

10.  Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.

Authors:  Christine Rønne Hansen; Tacjana Pressler; Christian Koch; Niels Høiby
Journal:  J Cyst Fibros       Date:  2005-03       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.